KitchenAid mixers, attachments, and more are all on sale during Prime Big Deal Days
Need we even tell you why KitchenAid stand mixers are great? Probably not. If you're looking to pick up one of the iconic ...
FDA antidepressant warnings of suicide risk among kids may have the opposite effect, study finds
FDA black box warnings that antidepressants may be linked with suicidality among youth may have unintended, yet harmful, ...
Straight Arrow News on MSN1dOpinion
Trump wants 200% tariff on foreign cars, here's how to tell where a car was made
Former President Trump is warning automakers not to move their production to Mexico. There's an easy way to know where cars ...
Medscape1d
FDA Antidepressant Warnings Tied to Increase in Suicidality
New data suggest that black box warnings of suicidality risk are associated with a decline in mental health care and an ...
Total Pro Sports1d
Tyson Fury Issues Bold Warning To Fellow Countryman Anthony Joshua; Believes He Will “ Never Escape”
Tyson Fury reveals he is not ready to let the fight with fellow Brit Anthony Joshua slide, believes their paths will cross.
Flow Space on MSN5d
New Campaign Urges FDA to Remove Misleading Warnings on Life-Saving Vaginal Estrogen Products
An outdated "boxed" warning on vaginal estrogen products is discouraging doctors from prescribing them and keeping women from ...
Invivyd Announces U.S. FDA Has Updated the PEMGARDA™ EUA Fact Sheet with Accurate SARS-CoV-2 Variant Susceptibility and PEMGARDA Activity Data
KP.3.1.1 and LB.1 in vitro neutralization potency values now reflected in the PEMGARDA Fact Sheet for Healthcare Providers are in-line with prior ...
verywellhealth8d
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
Business Wire10d
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treat…
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in ...
BioWorld11d
US FDA clears Cobenfy, first new schizophrenia drug in decades
The U.S. FDA has approved Cobenfy, a dual M1/M4 muscarinic agonist that offers a fundamentally different approach to treating schizophrenia. The fixed dose combination of xanomeline-trospium is the ...